Insider Transactions Reported by 22 Insiders of Onconetix, Inc.

Symbol
ONCO on Nasdaq
Location
Cincinnati, OH

There are no Buy or Sell transactions made by insiders since 30 Jan 2025

Onconetix, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joseph Hernandez CEO, Director, 10%+ Owner $11,490,960 09 May 2023
Cincinnati Cornerstone Investors BWV I, LLC 10%+ Owner $4,764,872 10 Apr 2023
Ralph Schiess Interim CEO, CSO $1,106,888 20 Dec 2024
Christian Bruhlmann Chief Strategy Officer $968,521 20 Dec 2024
Erin Henderson Chief Business Officer $717,077 09 May 2023
Jon Garfield Chief Financial Officer $410,340 09 May 2023
Vuk Jeremic Director $26,098 31 May 2023
JAMES SAPIRSTEIN Director $26,098 26 Sep 2024
Altos Venture AG 10%+ Owner $21,858 14 Jul 2025
Simon Tarsh Director $2,112 15 Aug 2025
Timothy Ramdeen Director $2,112 15 Aug 2025
Thomas Meier Director $2,108 15 Aug 2025
Andrew Oakley Director $2,047 15 Aug 2025
Neil Campbell Chief Executive Officer, Director 04 Oct 2023
Bruce Harmon Chief Financial Officer 04 Oct 2023
Allan Shaw Director 19 Aug 2022
Michael Venerable Director 04 May 2022
Kimberly M. Murphy Director 04 May 2022
John McCune Rice Jr. Director 17 Feb 2022
Sarah Romano Director 05 Dec 2025
Karina M. Fedasz Interim CFO 10 Jun 2024
Ajit Singh Director 26 Sep 2024

Recent Insider Transactions by Companies or Individuals for Onconetix, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.